Guo-Qing Jiang Selected Research

Procalcitonin

10/2016

Laparoscopic azygoportal disconnection with and without splenectomy for portal hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guo-Qing Jiang Research Topics

Disease

16	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 04/2012
16	Fibrosis (Cirrhosis) 12/2023 - 04/2012
15	Hypersplenism (Anemia, Splenic) 11/2023 - 01/2014
13	Portal Hypertension 11/2023 - 01/2014
13	Hemorrhage 11/2023 - 01/2014
12	Neoplasms (Cancer) 12/2023 - 08/2014
7	Flatulence 10/2022 - 04/2012
7	Thrombosis (Thrombus) 01/2022 - 10/2015
5	Pain (Aches) 04/2023 - 01/2014
3	Neoplasm Metastasis (Metastasis) 03/2023 - 01/2021
2	Fever (Fevers) 01/2022 - 10/2016
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2020 - 01/2014
2	Postoperative Hemorrhage 11/2018 - 10/2015
2	Ovarian Epithelial Carcinoma 11/2008 - 04/2008
1	Cholangiocarcinoma 03/2023
1	Down Syndrome (Down's Syndrome) 01/2022
1	Hepatitis B 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Carcinogenesis 01/2020
1	Lymphatic Metastasis 08/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Body Weight (Weight, Body) 01/2018
1	Varicose Veins (Varicose Vein) 02/2017
1	Wounds and Injuries (Trauma) 01/2017
1	Hemangioma (Angioma) 11/2015
1	Pleural Effusion (Pleural Effusions) 10/2015
1	Infections 10/2015
1	Breast Neoplasms (Breast Cancer) 08/2014
1	Granuloma 08/2014
1	Adenocarcinoma 11/2008
1	Ovarian Neoplasms (Ovarian Cancer) 04/2008

Drug/Important Bio-Agent (IBA)

14	Lysergic Acid Diethylamide (LSD)IBA 11/2023 - 10/2015
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2023 - 10/2017
3	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 07/2016
2	Cell-Free Nucleic AcidsIBA 01/2024 - 01/2021
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2023 - 01/2020
2	Biological FactorsIBA 08/2021 - 01/2021
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2019 - 07/2016
1	Messenger RNA (mRNA)IBA 10/2023
1	Carrier Proteins (Binding Protein)IBA 10/2023
1	Insulin-Like PeptidesIBA 10/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	Collagen Type IV (Type IV Collagen)IBA 01/2023
1	BuffersIBA 01/2022
1	Circular RNAIBA 01/2022
1	Ligases (Synthetase)IBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	CM 2-3IBA 01/2021
1	UbiquitinIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	Gefitinib (Iressa)FDA Link 01/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020
1	GlutaminaseIBA 08/2019
1	Proteins (Proteins, Gene)FDA Link 08/2019
1	Serum AlbuminIBA 01/2018
1	ProcalcitoninIBA 10/2016
1	C-Reactive ProteinIBA 10/2016
1	Hemoglobins (Hemoglobin)IBA 12/2014
1	Fluorouracil (Carac)FDA LinkGeneric 08/2014
1	Carboplatin (JM8)FDA LinkGeneric 11/2008
1	1-dodecylpyridoxal (PLD)IBA 11/2008
1	liposomal doxorubicin (Doxil)FDA Link 11/2008

Therapy/Procedure

21	Splenectomy 11/2023 - 01/2014
11	Length of Stay 04/2023 - 04/2012
4	Therapeutics 01/2023 - 07/2016
4	Blood Transfusion (Blood Transfusions) 01/2022 - 01/2014
3	Hepatectomy 02/2017 - 11/2015
2	Radiofrequency Ablation 12/2023 - 03/2023
2	Operative Surgical Procedures 01/2021 - 01/2014
1	Liver Transplantation 03/2023
1	Ligation 11/2018
1	Autologous Blood Transfusion 12/2014
1	Drug Therapy (Chemotherapy) 08/2014
1	Fluid Therapy (Oral Rehydration Therapy) 04/2012
1	Neoadjuvant Therapy 04/2008
1	Cytoreduction Surgical Procedures 04/2008
1	Adjuvant Chemotherapy 04/2008